• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec1
Roberto Mignone Disposes of Teva Pharmaceutical Ordinary Shares
21:03
Nov26
Bridger Management Plans to Sell 50,000 Restricted Shares of Teva Pharmaceutical
21:11
Jefferies Maintains Buy Rating on Teva and Sets Price Target
13:32
Nov25
Teva Pharmaceuticals Addresses AMR Through Responsible Antibiotic Production
19:36
Teva Pharmaceutical's denosumab biosimilars win European approval
13:10
Nov21
Teva Pharmaceuticals to Attend Piper Sandler Healthcare Conference
21:30

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 4.48 B, Net Income 433 M, EPS 0.37

Jul30
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 4.176 B, Net Income 282 M, EPS 0.24

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 3.891 B, Net Income 214 M, EPS 0.18

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
GURE
8.190
+72.78%
+3.450
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
View More